Micelle-engineered nanoplatforms for precision oncology

dc.authorscopusidAli Zarrabi / 23483174100
dc.authorwosidAli Zarrabi / U-2602-2019
dc.contributor.authorGao, Wei
dc.contributor.authorBigham, Ashkan
dc.contributor.authorGhomi, Matineh
dc.contributor.authorZarrabi, Ali
dc.contributor.authorRabiee, Navid
dc.contributor.authorSaeb, Mohammad Reza
dc.contributor.authorErtaş, Yavuz Nuri
dc.contributor.authorGoel, Arul
dc.contributor.authorSharifi, Esmaeel
dc.contributor.authorAshrafizadeh, Milad
dc.contributor.authorSethi, Gautam
dc.contributor.authorTambuwala, Murtaza M.
dc.contributor.authorWang, Yuzhuo
dc.contributor.authorGhaffarlou, Mohammadreza
dc.contributor.authorJiao, Taiwei
dc.date.accessioned2025-04-18T10:15:17Z
dc.date.available2025-04-18T10:15:17Z
dc.date.issued2024
dc.departmentİstinye Üniversitesi, Mühendislik ve Doğa Bilimleri Fakültesi, Biyomedikal Mühendisliği Bölümü
dc.description.abstractThe alliance between nanomaterials and cancer therapy has revolutionized the treatment of tumor patients. After cardiovascular diseases, cancer is the leading cause of death, so interdisciplinary approaches should be used for the treatment of this malignant disease. Both treatment and early diagnosis of cancer are challenging. The micelles belong to lipid-based nanostructures, and they have a hydrophobic core with hydrophilic head regions. The current review article focuses on the application of micelles in cancer suppression. The micelles can provide a platform for co-delivery of non-coding RNAs and RNAi in cancer gene therapy. Both synthetic and natural
dc.identifier.citationGao, W., Bigham, A., Ghomi, M., Zarrabi, A., Rabiee, N., Saeb, M. R., ... & Jiao, T. (2024). Micelle-engineered nanoplatforms for precision oncology. Chemical Engineering Journal, 495, 153438.
dc.identifier.doi10.1016/j.cej.2024.153438
dc.identifier.endpage29
dc.identifier.issn1385-8947
dc.identifier.issn1873-3212
dc.identifier.scopus2-s2.0-85197544416
dc.identifier.scopusqualityQ1
dc.identifier.startpage1
dc.identifier.urihttp://dx.doi.org/10.1016/j.cej.2024.153438
dc.identifier.urihttps://hdl.handle.net/20.500.12713/7006
dc.identifier.volume495
dc.identifier.wosWOS:001270754100001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorZarrabi, Ali
dc.institutionauthoridAli Zarrabi / 0000-0003-0391-1769
dc.language.isoen
dc.publisherElsevier science
dc.relation.ispartofChemical engineering journal
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMicelles
dc.subjectCancer Therapy
dc.subjectCancer Diagnosis
dc.subjectDrug Resistance
dc.subjectGene Therapy
dc.titleMicelle-engineered nanoplatforms for precision oncology
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
1-s2.0-S1385894724049271-main.pdf
Boyut:
26.99 MB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: